XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
2.150
-0.020 (-0.92%)
Sep 28, 2026, 12:46 PM EDT - Market open
XBiotech Employees
XBiotech had 87 employees as of June 30, 2026. The number of employees decreased by 5 or -5.43% compared to the same quarter last year.
Employees
87
Change
-5
Growth
-5.43%
Revenue / Employee
n/a
Profits / Employee
-$518,770
Market Cap
65.55M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 87 | -5 | -5.43% |
| Mar 31, 2026 | 87 | -3 | -3.33% |
| Dec 31, 2025 | 85 | -7 | -7.61% |
| Sep 30, 2025 | 88 | -4 | -4.35% |
| Jun 30, 2025 | 92 | -2 | -2.13% |
| Mar 31, 2025 | 90 | -2 | -2.17% |
| Dec 31, 2024 | 92 | 10 | 12.20% |
| Sep 30, 2024 | 92 | 7 | 8.24% |
| Jun 30, 2024 | 94 | 10 | 11.90% |
| Mar 31, 2024 | 92 | 8 | 9.52% |
| Dec 31, 2023 | 82 | -3 | -3.53% |
| Sep 30, 2023 | 85 | -8 | -8.60% |
| Jun 30, 2023 | 84 | -12 | -12.50% |
| Mar 31, 2023 | 84 | -13 | -13.40% |
| Dec 31, 2022 | 85 | -12 | -12.37% |
| Sep 30, 2022 | 93 | -2 | -2.11% |
| Jun 30, 2022 | 96 | 2 | 2.13% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 214 |
| Gossamer Bio | 162 |
| Alps Group | 93 |
| MindWalk Holdings | 77 |
| Connect Biopharma Holdings | 64 |
| Pliant Therapeutics | 49 |
| Cingulate | 14 |
| Alterity Therapeutics | 11 |
XBIT News
- 3 months ago - XBiotech to enroll patients in vilamakitug trial following FDA review - TheFly
- 3 months ago - XBiotech Launches Phase II Clinical Trial Evaluating Vilamakitug for the Treatment of Active Axial Spondyloarthritis - GlobeNewsWire
- 1 year ago - XBiotech trading resumes - TheFly
- 1 year ago - XBiotech pauses rheumatology program - TheFly
- 1 year ago - XBiotech trading halted, news pending - TheFly
- 1 year ago - XBiotech Pauses Rheumatology program - GlobeNewsWire
- 2 years ago - XBiotech trading resumes - TheFly
- 2 years ago - XBiotech announces data from Phase 1/2 1-BETTER study - TheFly